共 50 条
- [41] Exposure-response Modeling From the CLARITY Trial of Pimavanserin for Adjunctive Treatment of Major Depressive Disorder CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (05): : 463 - 474
- [43] The association of COMT genotype with buproprion treatment response in the treatment of major depressive disorder BRAIN AND BEHAVIOR, 2020, 10 (07):
- [49] Gene expression biomarkers of response to citalopram treatment in major depressive disorder TRANSLATIONAL PSYCHIATRY, 2011, 1 : e13 - e13